Longevity UnmaskedLongevity Unmasked

Question 71 of 433

How should fatty liver be checked?

Evidence grade (draft mapping)GGuideline-based / consensus
Bright lab pipette dispensing into a sample plate

The short answer

In adults at risk of metabolic liver disease, a staged assessment often begins with routine tests and a fibrosis calculation such as FIB-4. It estimates risk; it does not diagnose scarring by itself.

FIB-4 uses age, AST, ALT, and platelet count. In many primary-care pathways a value below 1.3 suggests lower risk, while a higher result prompts a second assessment such as elastography or an ELF blood test. Values above 2.67 often justify specialist evaluation. Interpretation changes after age 65, is less reliable under 35, and should not be applied casually during acute illness.

Normal liver enzymes do not rule out important disease. Diabetes, obesity, alcohol, medication, and other liver conditions all influence the assessment. An elastography result must also be interpreted in context rather than treated as a stand-alone diagnosis.

Sustained weight loss can reduce liver fat and inflammation, and larger losses can improve fibrosis in some people. Treatment is tailored to severity and cause. A change in one blood number is not proof that scarring has resolved.

“This book is for education. It is not medical advice, and reading it does not make you my patient or create a doctor-patient relationship.” From the book’s medical disclaimer. Full disclaimer

Evidence scope
GUIDELINE-BASED — Adults at risk of metabolic liver disease: sequential fibrosis assessment; age and clinical setting affect cutoffs.Evidence grade (draft mapping)GGuideline-based / consensusPart 5, Q71 · Sources: R8

Sources cited

All of Part 5

Related questions